Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ... Extramedullary plasmacytoma and solitary plasmacytoma represent rare manifestations of plasma cell dyscrasias, where abnormal plasma cells accumulate as a single localised lesion.

Understanding the Context

In the case of ... Multiple myeloma is a cancer of plasma cells, the antibody-making white blood cells that live in your bone marrow. When these cells turn abnormal and multiply, they crowd out healthy blood-forming ... ascopubs.org: Evaluation of immune checkpoint inhibitors and concurrent radiation therapy for the treatment of extramedullary multiple myeloma.

Key Insights

Beyond the numbers: Dissecting racial and gender disparities in myeloma mortality. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ... Evaluation of immune checkpoint inhibitors and concurrent radiation therapy for the treatment of extramedullary multiple myeloma. The American Journal of Managed Care: Optimizing Approaches to CAR T, Bispecific Therapies in Myeloma and Lymphoma Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

Final Thoughts

Various factors play a role in whether or not a patient is ...